| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Efficacy · Boundaries · MaterialsWhat are the selected original question and assessment record?Required |
The selected original question is reduced diabetes incidence by the prespecified nine-year definition. Its subclaim record is distinguished from the parent and sibling FPG-only definition context. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. No independent-claim certification, new subclaim split or invented main verdict was made. |
Korean/English wording and record link for reduced diabetes incidence by the prespecified nine-year definition |
If the question boundary changes, retain the original wording, previous complete version and change event separately. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Efficacy · Boundaries · MaterialsHow do subclaim D and parent D34, axes and history differ?Required |
The subclaim is D, with “RR 0.88, P=.24, a null result”; it has no score, status or axes keys. Parent D34, Good safety, B/H/R1/I2/E0/B1/C0 and the true large hard-outcome RCT flag are retained as parent context. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Selected-row score, status and axes are unrecorded; parent values are not inserted. |
Subclaim grade/note, absent score/status/axes and actual parent values |
Separate preservation of original values from a new decision event when evidence is actually updated. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Efficacy · Boundaries · MaterialsWhich high-risk community residents were selected?Required |
In 60 polling areas in Kerala, India, 1,007 residents aged 30-60, without diabetes and with IDRS at least 60, were allocated. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Baseline diabetes-exclusion testing, IDRS components, prediabetes proportion, sex, baseline glucose/weight, selection and representativeness details are unverified. |
Kerala, India; ages 30-60; IDRS at least 60; no baseline diabetes |
Distinguish other high-risk groups using their actual risk definitions and selection materials. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Efficacy · Boundaries · MaterialsWhat was the actual peer-led intervention?Required |
The original intervention was a 12-month monthly group lifestyle program led by trained community peers, distinct from expert-led intensive interventions. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Session content, education/support, peer training, delivery quality, attendance and actual implementation are unverified. |
Trained community peers and monthly group lifestyle sessions |
Record actual program identity, intensity, delivery and peer roles together in subsequent materials. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Efficacy · Boundaries · MaterialsAre the 12-month program and nine-year outcome period distinguished?Required |
The program consisted of monthly sessions for 12 months; the selected outcome is cumulative diabetes incidence at nine years. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Maintenance, additional sessions, other care, individual follow-up duration and visit windows after the program are unverified. |
Initial intervention duration, long-term follow-up and maintenance/additional exposure |
Report original intervention duration separately from maintenance/additional exposure during follow-up. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Efficacy · Boundaries · MaterialsWhat were the control and direction of comparison?Required |
The 500 intervention participants received the monthly peer-led program; 507 control participants received an education booklet. The control is not relabeled as no education or no treatment. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Booklet content, distribution/reading, actual control care and differences in education common to both groups are unverified. |
Education-booklet control and original intervention/control correspondence |
Do not automatically combine materials using a different control as the same comparison. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Efficacy · Boundaries · MaterialsWhat were the cluster-allocation unit and number?Required |
This trial cluster randomized 60 polling areas. The 500/507 allocation among 1,007 individuals represents people. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Clusters per group, cluster sizes, recruitment order, post-allocation selection, retention of all clusters and concealment are unverified. |
60 polling-area clusters, distinguished from individual recruitment/analysis |
Record cluster and individual recruitment, allocation, follow-up and analysis together. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Efficacy · Boundaries · MaterialsWhat were the allocation, masking and diagnostic-collection processes?Required |
The original design is recorded as long-term follow-up of a cluster-randomized controlled trial. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Allocation generation/concealment, facilitator/resident masking, tester/adjudicator/analyst masking and outcome-collection details are unverified. |
Cluster allocation concealment, participant/assessor masking and outcome collection |
When methods are provided, link actual role-specific masking and diagnostic collection to the corresponding outcome. |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Efficacy · Boundaries · MaterialsWhat were long-term co-interventions and cluster contamination?Required |
The original summary retains nine-year outcomes for the program versus education booklet. |
Required direct values, definitions or materials are unverified within the current stored-summary/unread-external-material scope. Other lifestyle support, weight/activity changes, preventive medication, medical access, contact/contamination between clusters and group differences during follow-up are unverified. |
Diet, activity, medicines, other programs and contact between clusters |
Record actual measurement/management of post-intervention exposure and cluster contamination in subsequent research. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Efficacy · Boundaries · MaterialsWhat were the components of the prespecified diabetes-incidence definition?Required |
The prespecified primary definition is cumulative incidence based on FPG at least 126 mg/dL or HbA1c at least 6.5%, including physician diagnosis or initiation of glucose-lowering medication during follow-up. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Detailed confirmation of each criterion, repeat testing, record sources, component-specific events and overlap are unverified. |
FPG at least 126 mg/dL or HbA1c at least 6.5%, plus physician diagnosis/medication initiation during follow-up |
Link each criterion, combination rule and overlap separately in new definition materials. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Efficacy · Boundaries · MaterialsHow were glucose and HbA1c measured and confirmed?Required |
The original incidence criteria include FPG and HbA1c thresholds. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Fasting confirmation, blood sampling/assays, repeat confirmation, testing by visit, failed/indeterminate tests and adjudicator details are unverified. |
Fasting tests, assay methods, repeat confirmation, timing and missingness |
Distinguish collection of test-based incidence from physician-diagnosis/medication-based incidence. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Efficacy · Boundaries · MaterialsHow were physician diagnosis and glucose-lowering medication initiation included?Required |
The original prespecified definition includes physician diagnosis and initiation of glucose-lowering medication during follow-up. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Medical-record/self-report sources, initiation indications, diabetes confirmation, component overlap and event dates are unverified. |
Sources, confirmation and incidence attribution for diagnosis/medication initiation |
Link actual criterion-specific attribution and overlap when registration/plans and result tables are provided. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Efficacy · Boundaries · MaterialsWhat time and analysis measure does nine-year cumulative incidence represent?Required |
The selected primary outcome is nine-year cumulative diabetes incidence, recorded as an available-case analysis. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Individual follow-up duration, testing/diagnostic visit intervals, event dates, censoring, death/competing-event handling and person-time are unverified. |
Nominal nine years, cumulative incidence, analysis population and follow-up duration |
Distinguish cumulative incidence risk, incidence rate and time models in new time-related materials. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Efficacy · Boundaries · MaterialsWhat were the original nine-year event numerators, denominators and proportions?Required |
The stored summary records prespecified nine-year outcomes as intervention 125/419 (30%) versus control 142/422 (34%). |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Component-specific events, repeated counts, overlap by person and original-table details are unverified. |
Attribution of intervention 125/419 (30%) and control 142/422 (34%) |
Link original numerators, denominators and proportions to the corresponding definition/time point as materials are supplemented. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Efficacy · Boundaries · MaterialsWhat is the scope of the RR, interval, P value and null-result wording?Required |
The prespecified nine-year result is RR 0.88 (95% CI 0.73-1.08), P=.24; the original subclaim D/note records a null result. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Model, cluster adjustment, adjustment variables, estimand and interval-calculation details are unverified. |
RR 0.88, 95% CI 0.73-1.08, P=.24 and analysis/adjustment |
Link the estimate to its adjustment and units when original methods are provided. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Efficacy · Boundaries · MaterialsWhat were the randomized and actual nine-year analysis denominators?Required |
Allocation was 1,007 participants (500 intervention/507 control); actual nine-year data analysis used 841 (419/422). The original summary says available cases rather than all randomized participants. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Group-specific exclusion reasons, valid-data criteria, cluster retention in analysis and alternative analyses based on full allocation are unverified. |
1,007 randomized (500/507) and 841 available cases (419/422) |
Link allocation, acquired data, valid outcomes and actual analysis denominators separately when follow-up data are added. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Efficacy · Boundaries · MaterialsAre the 144 lost to follow-up and 841 analyzed distinguished?Required |
The source separately records loss to follow-up of 144/1,007 (14.3%) and the historical assessment of below 15%; it records 841 in the nine-year analysis. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Relationships among exclusions beyond loss to follow-up, indeterminate data, death and group-specific reasons are unverified. |
Original loss to follow-up, 144/1,007 (14.3%), and analysis flow |
Link definitions and reasons for each state when original flow materials are supplemented. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Efficacy · Boundaries · MaterialsWhat were the available-case and missingness/selection assumptions?Required |
The original rationale records nine-year available-case analysis as a limitation. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Cluster/individual missingness reasons, mechanisms, additional analyses, imputation, inverse-probability/sensitivity analysis use and results are unverified. |
Analysis of people with data, missingness reasons and imputation/sensitivity analyses |
Distinguish analysis of people with data from assumptions for the full allocated population. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Efficacy · Boundaries · MaterialsWhat were the cluster correlation, sizes and estimation model?Required |
The original design is a 60-cluster randomized controlled trial, and the stored summary supplies RR/CI results. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. ICC, cluster sizes, events per cluster, within-person repetition, variance/weighting and whether estimates were cluster adjusted are absent from the summary. |
Cluster structure, ICC, cluster-adjusted estimation, weighting/repeated measures |
Link actual cluster correlation/weighting to the original estimand when cluster data are added. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Efficacy · Boundaries · MaterialsWhat were the prespecified primary definition and outcome hierarchy?Required |
The stored summary identifies the FPG/HbA1c, physician-diagnosis and medication-initiation definition as prespecified primary; it says FPG alone was not the prespecified primary definition. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Designation dates, changes, definition/analysis hierarchy and multiplicity details are unverified because external plans are unread. |
Prespecified nine-year definition, analysis plan and multiple definitions/tests |
Link the contemporary prespecified/post hoc status, change history and outcome definition when plans are provided. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Efficacy · Boundaries · MaterialsWhat separate definition produced the positive FPG-only result?Required |
The FPG-only definition gives RR 0.72 (95% CI 0.53-0.98), P=.036. Sibling s1 is C and says it was not the prespecified primary endpoint. Both this and selected s0’s null result are preserved. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Actual FPG-only numerators/denominators, valid-testing population, other definition results, adjustment and multiple testing are unverified. |
RR 0.72, 95% CI 0.53-0.98, P=.036 and difference from the selected definition |
Link results for each definition to separate measures/denominators even at the same time point. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Efficacy · Boundaries · MaterialsHow do the original paired registration identifiers and actual content-reading state differ?Required |
The original evidence record gives “ACTRN12611000262909 · CTRI/2021/10/037191”. The paired original values are preserved. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Registration content, dates, changes, nine-year-plan correspondence and public results were not read/confirmed in this work. Citations have no separate registration-number key. |
ACTRN12611000262909 · CTRI/2021/10/037191 and current reading scope |
Distinguish original identity, dates, changes and actual reading scope when registration materials are provided. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Efficacy · Boundaries · MaterialsWhat are the bibliographies and stored-source locations of the two reports?Required |
R01 is Jeemon et al., 2026 Lancet Global Health, nine-year K-DPP, PMID 41997166. R02 is Thankappan et al., 2018 Diabetes Care, the earlier 24-month report, PMID 29874236. The source has one evidence entry and two citations. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. DOIs, PMCIDs, current external bibliographies and original table/method locations are not provided. |
Jeemon 2026 nine-year report, Thankappan 2018 24-month report and PMIDs |
Retain previous original values and each report’s identity when bibliographies are supplemented/corrected. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Efficacy · Boundaries · MaterialsAre the earlier report and long-term follow-up from the same trial?Required |
The original research account and second citation identify 24 months as an earlier report from the same trial. Nine years is long-term follow-up of the 60-cluster trial. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Actual participant links, cluster retention and time-specific outcomes are externally unread; unique trial/participant counts are not newly certified. |
2018/2026 K-DPP clusters/participants and report family |
Distinguish genuinely different recruitment/registration when an independent new trial is provided. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Efficacy · Boundaries · MaterialsWhat separate time point does the original 24-month result represent?Required |
At 24 months, the same trial reported 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (95% CI 0.66-1.16), P=.36. The RR matches nine years numerically, but time, denominators, interval and P differ. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Original 24-month diagnostic definition, testing, missingness/model and person-specific links to nine years are unverified. |
68/456(14.9%)·79/463(17.1%)·RR0.88·CI/P |
Record each time point’s definition, denominators and effect separately when materials are provided. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Efficacy · Boundaries · MaterialsWhat heterogeneity was assessed by high-risk subgroup and period?Required |
The source retains the selected overall population’s nine-year available-case result. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Prespecified subgroups and interaction results for prediabetes/baseline glucose, sex, cluster, attendance and period are unverified. |
Baseline glucose/risk, sex, cluster, time and actual effects |
Report actual prespecified criteria and intervals for group/time differences in subsequent materials. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Efficacy · Boundaries · MaterialsAre the monthly peer-led program and expert-led intensive interventions distinguished?Required |
The original account says this does not mean all expert-led intensive diet, exercise and behavioral programs are ineffective. DPP, DPS and verdict 1531 A94 are historical context for a different question. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Original texts of other programs, direct intensity/facilitator superiority comparisons and general applicability were not queried here. |
Identity of the low-cost peer-led program and direct evidence for different intensity/facilitators |
Specify program identity, population, intensity and control in new applicability materials. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Efficacy · Boundaries · MaterialsHow does actual diabetes incidence differ from other outcomes?Required |
The selected outcome is prespecified diabetes incidence, not short-term glucose, weight or risk-score change itself. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Direct nine-year complication, death, quality-of-life and other metabolic-outcome values/denominators are absent from this source. |
Incidence events versus risk-score/glucose changes, complications and death |
Link incidence, surrogate markers and complications to their own definitions and time points. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Efficacy · Boundaries · MaterialsWhat is the scope of NHMRC support and no commercial product?Required |
The source records support by the Australian National Health and Medical Research Council and no commercial product used. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Each report’s author interests, funder design/analysis/publication roles, sponsor and current relationship declarations are unread. |
Trial funding, products, facilitator/analysis/publication roles and disclosed relationships |
Distinguish public funding, commercial products and other relationships/roles when support materials are provided. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Efficacy · Boundaries · MaterialsWhat were the original date, Korean/English text, corrections, empty fields and verdict history?Required |
The reference date is 2026-08-26, corrections are an empty array and deliberation an empty string. Korean/English text, synthesis, grade-decision records, axes and false/true flags are preserved in the complete source. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Separate facets and primary-failed/secondary-positive keys are absent. Empty corrections are not a current external correction/retraction check. |
2026-08-26, empty correction/deliberation records and original axes/grades |
Retain the complete original text, event, version and separate application when changes occur. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Efficacy · Boundaries · MaterialsWhat level of material was actually read for this work?Required |
Preparation read the complete preserved 2963 JSON and its selected original question. Report-specific summary reading is separated from unread external-material slots. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. External abstracts, full texts, registrations, plans, original results/harms and funding declarations were not accessed/acquired. Historical abstract/report wording is not current reading. |
Complete preserved JSON, own selected question and unread external materials |
Distinguish public availability, access, acquisition, actual reading, scope and dates for new materials. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Efficacy · Boundaries · MaterialsHow do report/material slots differ from trials/populations?Required |
The two reports are the same trial’s nine-year follow-up and earlier 24-month report. Material slots are preparation counts linking reading/required materials. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. No new calculation/certification of unique trials, total participants or independent replication was made. |
Two bibliographies, material-specific states and shared clusters/people/time points |
Distinguish material types and same/different-population relationships when additional reports appear. |
| 33 |
Partly verified |
Full text not readStored summary read |
N33 · Efficacy · Boundaries · MaterialsWhat is updated when new material appears?Required |
The original question and original numbers/verdict are prepared in the same seven-column format. Conditions were saved/frozen first; observations were written at a separate application time. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. No new search, calculation, evidence/effect, regrading, independent certification or model/self-review was performed. |
Separation of conditions, originals, observations, reading and change events |
For actual additions/changes, separately retain the previous complete text, event, condition version/freeze, application and current handoff. |
| 34 |
Partly verified |
Full text not readStored summary read |
H01 · HarmsHow were adverse events and intervention relatedness defined?Supporting harm information |
The original 24-month report is recorded as having no intervention-related adverse events; the nine-year abstract is recorded as providing no separate safety-outcome counts. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. All adverse events, relatedness assessment, collection/severity criteria and outcome-specific definitions are unverified. |
Adverse events, relatedness, severity and collection |
Record all collected harms separately from judgments of intervention relatedness. |
| 35 |
Partly verified |
Full text not readStored summary read |
H02 · HarmsHow do safety observations at 12-month exposure, 24 months and nine years differ?Supporting harm information |
The program lasted 12 months; the 24-month related-event account and absence of nine-year abstract safety counts are retained separately. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Actual start/end of safety collection, post-intervention events, long-term care exposure and collection frequency are unverified. |
Intervention duration, safety-collection timing and long-term exposure |
Record intervention exposure separately from actual observation duration in long-term harms materials. |
| 36 |
Unverified |
Full text not readStored summary read |
H03 · HarmsIs there a nine-year between-group safety comparison?Supporting harm information |
The original source says the nine-year abstract had no separate safety counts. Those external abstracts/full texts were not read in this work. |
Required direct values, definitions or materials are unverified within the current stored-summary/unread-external-material scope. Group-specific harms, serious events, related events, CIs and diagnosis/observation are unverified within the current unread-external-material scope. |
Nine-year intervention/control harms, relatedness and intervals |
Link new harms results to actual group-specific definitions, denominators and periods. |
| 37 |
Partly verified |
Full text not readStored summary read |
H04 · HarmsAre safety denominators the same as incidence-analysis denominators?Supporting harm information |
The source gives 1007 allocated for incidence, 841 analyzed at nine years and 456/463 for 24-month outcomes, but no separate safety-analysis denominator. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Harms-collection, intervention-exposure, period-specific safety populations/clusters and missingness denominators are unverified. |
Harms collection/exposure/analysis n, clusters and individuals |
Distinguish actual harms collection/analysis populations from incidence denominators. |
| 38 |
Unverified |
Full text not readStored summary read |
H05 · HarmsWhat alternative explanations link lifestyle/care changes and harms?Supporting harm information |
The source only supplies the account of no intervention-related adverse events at 24 months. |
Required direct values, definitions or materials are unverified within the current stored-summary/unread-external-material scope. Baseline risks, co-interventions, other programs, background events, relatedness adjudication and case details are unverified. |
Baseline disease, other activities/medicines, relatedness and timing |
Distinguish program-related events from baseline/concurrent factors in harms materials. |
| 39 |
Partly verified |
Full text not readStored summary read |
H06 · HarmsAre unread materials, absence from an abstract, nonreporting and zero events distinguished?Supporting harm information |
The original safety account distinguishes missing nine-year abstract safety counts from no related events at 24 months. Currently, the preserved JSON summary was actually read. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Noncollection/nonreporting/indeterminate/actual-zero distinctions in external originals and all harms outcomes are unverified. |
Original historical reading narrative and current unread state |
Distinguish actual collection, nonreporting, missingness and zero at the corresponding location/time when materials are provided. |
| 40 |
Partly verified |
Full text not readStored summary read |
H07 · HarmsAre harms from the same cohort kept from being counted as independent replication?Supporting harm information |
The two reports are earlier results and long-term follow-up of the same cluster trial; harms status at each time point is retained separately. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Repeated/new events, individual/cluster relationships and long-term harms counts are unverified. |
24 months/nine years, people, events and report family |
Distinguish repeated/new events, time points and actual counts in added harms materials. |
| 41 |
Partly verified |
Full text not readStored summary read |
H08 · HarmsWhat gaps concern other risk groups, intensity and long-term safety?Supporting harm information |
The parent safety status is Good; this question covers a specific peer-led program among high-risk Kerala residents. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. Direct materials for other ages, diseases, risk groups, intensities/expert-led programs and long-term harms are unverified in this source. |
Selected high-risk ages 30-60, monthly peer-led intensity and long-term harms |
Specify harms by actual population, intensity and exposure duration in subsequent research. |
| 42 |
Partly verified |
Full text not readStored summary read |
H09 · HarmsAre the null incidence result and safety gaps both retained?Supporting harm information |
The prespecified nine-year incidence result is originally D/null. Historical no-related-event wording at 24 months and missing nine-year safety counts are retained separately as harms context. |
The corresponding stored-summary information is linked for preparation; this is not clinical confirmation, fulfillment of conditions or completed content review. No new benefit-harm synthesis, clinical treatment/prevention choice or implementation guidance was created. |
Separate interpretation of incidence results, related-event wording and long-term harms gaps |
Link effects, harms and change events to each original location when new materials are provided. |